Yves Lambert

Yves Lambert

Auto-generated profile, based on publicly available information

Yves Lambert

Centre Hospitalier de Versailles, SAMU 78 and Mobile Intensive Care Unit , Versailles

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2019 in Revue Neurologique
Verified
Journal Article
Closed access
CHC. Hirel
C. Hirel
LBL. Berton
L. Berton
CPC. Preda
C. Preda
ORO. Richard
O. Richard
YLY. Lambert
Y. Lambert
FPF. Pico
F. Pico

3 December 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ALAurélie Loyeau
Aurélie Loyeau
HBHakim Benamer
Hakim Benamer
SBSophie Bataille
Sophie Bataille
STSarah Tepper
Sarah Tepper
TBThévy Boche
Thévy Boche
FLFrédéric Lapostolle
Frédéric Lapostolle
Introduction: Recent studies reported a decrease in the incidence of acute myocardial infarction. This favorable evolution does not extend to young women. The interaction between gender, risk factors and myocardial infarction incidence remains controversial. Objective: To compare the evolution of the age pyramid of patients with ST-elevation myocardial infarction (STEMI) according to gender. Methods: Data from patients with STEMI managed in pre-hospital settings prospectively collected in the greater Paris area. Evolution of patient demographics and risk factors was investigated. Results: 28,249 patients with STEMI were included in the registry between 2002 and 2014, 21,883 (77%) males and 6366 (23%) females. The sex ratio did not significantly vary over the study period (p = 0.4). Median patient age was 60.1 years (51.1–73.0) and was significantly different between males and females, respectively 57.9 (50.0–68.3) vs. 72.9 years (58.3–82.2) (p = 0.0004). The median age of males significantly (p = 0.0044) increased from 57.6 (50.1–70.0) in 2002 to 58.1 years (50.5–67.8) in 2014. The median age of females significantly (p = 0.0006) decreased from 73.7 (57.9–81.8) to 69.6 years (57.0–82.4). The median gap between the age of men and women significantly (p = 0.0002) decreased, from 16.1 to 11.5 years. Prevalence of risk factors was unchanged or decreased except for hypertension which significantly increased in males. The rate of STEMI without reported risk factors increased in both males and females. Conclusion: The age of STEMI onset significantly decreased in females, whereas it significantly increased in males. The prevalence of risk factors decreased in males, whereas no significant variation was found in females.

1 December 2024 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
KBKevin R. Bainey
Kevin R. Bainey
RWRobert C. Welsh
Robert C. Welsh
YZYinggan Zheng
Yinggan Zheng
AAAlexandra Arias-Mendoza
Alexandra Arias-Mendoza
ARArsen D. Ristic
Arsen D. Ristic
OIon behalf of the STREAM-2 Investigators
on behalf of the STREAM-2 Investigators
BACKGROUND: In STREAM-1 (Strategic Reperfusion Early After Myocardial Infarction), excess intracranial hemorrhage occurred in patients aged ≥75 years receiving full-dose tenecteplase as part of a pharmaco-invasive strategy, whereas no further intracranial hemorrhage occurred after halving the tenecteplase dose. In STREAM-2 (Second Strategic Reperfusion Early After Myocardial Infarction), half-dose tenecteplase was an effective and safe pharmaco-invasive strategy in older patients with ST-segment–elevation myocardial infarction presenting within <3 hours, compared with primary percutaneous coronary intervention (PCI). We prespecified evaluating the efficacy and safety of a half-dose versus full-dose pharmaco-invasive strategy and compared the half-dose pharmaco-invasive strategy to primary PCI in patients aged ≥75 years. METHODS: We pooled data sets in patients aged ≥75 years from STREAM-1 and STREAM-2 receiving a pharmaco-invasive strategy versus primary PCI. Resolution of ST-segment–elevation after fibrinolysis and angiography was assessed, as was the relative risk of the primary composite of 30-day all-cause death, myocardial infarction, heart failure, and shock, along with bleeding. RESULTS: A total of 390 patients were included: 42 patients were randomized to full-dose pharmaco-invasive treatment, 205 patients to half-dose pharmaco-invasive treatment, and 143 patients to primary PCI. Half-dose versus full-dose pharmaco-invasive treatment resulted in similar proportions of patients achieving ≥50% ST-segment resolution posttenecteplase (63.2% versus 62.6%), with reduced intracranial hemorrhage (7.1% versus 0%, respectively). Half-dose pharmaco-invasive treatment and primary PCI also had similar proportions of patients with ≥50% ST-segment resolution postangiography (77.9% versus 72.4%; P =0.277) and comparable composite end points (23.4% versus 28.0%; relative risk, 0.90 [95% CI, 0.62–1.30]; P =0.567) without occurrence of intracranial hemorrhage. CONCLUSIONS: Comparable efficacy exists between half- and full-dose tenecteplase pharmaco-invasive treatments with improved safety in patients with ST-segment–elevation myocardial infarction aged ≥75 years. Half-dose pharmaco-invasive therapy is a legitimate therapeutic option for elderly patients with ST-segment–elevation myocardial infarction unable to access timely primary PCI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00623623. URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02777580.

1 January 2024 in Age and Ageing
Verified
Journal Article
Open access
PDF file
FLFrédéric Lapostolle
Frédéric Lapostolle
TPTomislav Petrovic
Tomislav Petrovic
BMBrice Moiteaux
Brice Moiteaux
ALAurélie Loyeau
Aurélie Loyeau
TBThévy Boche
Thévy Boche
YLYves Lambert
Yves Lambert
Background: The use of myocardial reperfusion—mainly via angioplasty—has increased in our region to over 95%. We wondered whether old and very old patients have benefited from this development. Methods: Setting: Greater Paris Area (Ile-de-France). Data: Regional registry, prospective, including since 2003, data from 39 mobile intensive care units performing prehospital treatment of patients with ST segment elevation myocardial infarction (STEMI) ( 70 years, 3,784 (14%) > 80 years and 672 (2%) > 90 years. The reperfusion decision rate was 94%. It decreased significantly with age: 93, 90 and 76% in patients in their seventh, eighth and ninth decade, respectively. The reperfusion decision rate increased significantly over time. It increased in all age groups, especially the higher ones. Mortality was 6%. It increased significantly with age: 8, 16 and 25% in patients in their seventh, eighth and ninth decade, respectively. It significantly decreased over time in all age groups. The odds ratio of the impact of reperfusion decision on mortality reached 0.42 (0.26–0.68) in patients over 90 years. Conclusion: the increase in the reperfusion decision rate was the greatest in the oldest patients. It reduced mortality even in patients over 90 years of age.

20 August 2025 in Annales de Cardiologie et d'Angéiologie
Verified
Journal Article
Closed access
FLFrédéric Lapostolle
Frédéric Lapostolle
HBHakim Benamer
Hakim Benamer
ALAurélie Loyeau
Aurélie Loyeau
HMHugo Michalak
Hugo Michalak
TPTomislav Petrovic
Tomislav Petrovic
YLYves Lambert
Yves Lambert

1 October 2024 in Circulation
Verified
Journal Article
Closed access
PSPeter R. Sinnaeve
Peter R. Sinnaeve
RWRobert C. Welsh
Robert C. Welsh
AAAlexandra Arias-Mendoza
Alexandra Arias-Mendoza
ARArsen D. Ristić
Arsen D. Ristić
OAOleg V. Averkov
Oleg V. Averkov
OIon behalf of the STREAM-2 Investigators
on behalf of the STREAM-2 Investigators